Carbetocin versus oxytocin for the prevention of postpartum haemorrhage following caesarean section: the results of a double‐blind randomised trial
Authors:
- 8 June 2010
- journal article
- research article
- Published by Wiley in BJOG: An International Journal of Obstetrics & Gynaecology
- Vol. 117 (8) , 929-936
Abstract
Please cite this paper as: Attilakos G, Psaroudakis D, Ash J, Buchanan R, Winter C, Donald F, Hunt L, Draycott T. Carbetocin versus oxytocin for the prevention of postpartum haemorrhage following caesarean section: the results of a double‐blind randomised trial. BJOG 2010;117:929–936.Objective To compare the effectiveness of carbetocin and oxytocin when they are administered after caesarean section for prevention of postpartum haemorrhage (PPH).Study design Double‐blind randomised single centre study (1:1 ratio).Setting Teaching hospital in Bristol, UK with 6000 deliveries per annum.Population Women at term undergoing elective or emergency caesarean section under regional anaesthesia, excluding women with placenta praevia, multiple gestation and placental abruption.Methods Women were randomised to receive either carbetocin 100 μg or oxytocin 5 IU intravenously after the delivery of the baby. Perioperative care was otherwise normal and use of additional oxytocics was at the discretion of the operating obstetrician. Analysis was by intention to treat.Primary outcome measure The proportion of women in each arm of the trial that needed additional pharmacological oxytocic interventions.Results Significantly more women needed additional oxytocics in the oxytocin group (45.5% versus 33.5%, Relative risk 0.74, 95% CI 0.57–0.95). The majority of women had oxytocin infusions. There were no significant differences in the secondary outcomes, including major PPH, blood transfusions and fall in haemoglobin.Conclusions Carbetocin is associated with a reduced use of additional oxytocics. It is unclear whether this may reduce rates of PPH and blood transfusions.Keywords
This publication has 12 references indexed in Scilit:
- Study Protocol. ECSSIT – Elective Caesarean Section Syntocinon® Infusion Trial. A multi-centre randomised controlled trial of oxytocin (Syntocinon®) 5 IU bolus and placebo infusion versus oxytocin 5 IU bolus and 40 IU infusion for the control of blood loss at elective caesarean sectionBMC Pregnancy and Childbirth, 2009
- Epidemiology of postpartum haemorrhage: a systematic reviewBest Practice & Research Clinical Obstetrics & Gynaecology, 2008
- Use of oxytocin to prevent haemorrhage at caesarean section—A survey of practice in the United KingdomEuropean Journal of Obstetrics & Gynecology and Reproductive Biology, 2008
- Haemodynamic effects of oxytocin given as i.v. bolus or infusion on women undergoing Caesarean sectionBritish Journal of Anaesthesia, 2006
- Caesarean delivery rates and pregnancy outcomes: the 2005 WHO global survey on maternal and perinatal health in Latin AmericaThe Lancet, 2006
- Comparison of Carbetocin and Oxytocin for the Prevention of Postpartum Hemorrhage Following Vaginal Delivery: A Double-Blind Randomized TrialJournal of Obstetrics and Gynaecology Canada, 2004
- The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trialsThe Lancet, 2001
- Double-blind comparison of carbetocin versus oxytocin in prevention of uterine atony after cesarean sectionAmerican Journal of Obstetrics and Gynecology, 1999
- Risk factors for major obstetric haemorrhageEuropean Journal of Obstetrics & Gynecology and Reproductive Biology, 1993
- Intra‐operative blood loss during elective lower segment caesarean sectionBJOG: An International Journal of Obstetrics & Gynaecology, 1992